8400 The Health Network
Vered Behar is the Co-Founder and Chief Executive Officer of Mylo Pharma, a pre-clinical biotech company focused on developing small molecule drugs for oncology and autoimmune diseases since March 2020. Behar is also a member of 8400 The Health Network (Cohort #6) as of November 2023. Previous roles include Vice President of R&D at MeMed Dx (July 2019 - January 2020), Chief Science Officer at Vidac Pharma (September 2012 - April 2019), and Vice President of R&D at Dynamix Pharmaceuticals (February 2009 - August 2012). Behar began a career in the biotech industry with roles such as Head of Biology at Third Rock Ventures and Chief Scientist at Quantomix. Educational qualifications include a PhD in Medical Sciences from Harvard Medical School, an MBA from The Hebrew University of Jerusalem, and participation in the Executive HealthTech program at Harvard Business School.
This person is not in the org chart
This person is not in any teams
8400 The Health Network
On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.